FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar

Abstract: A misguided federal program called the Unapproved Drugs Initiative, which put the FDA’s stamp of approval on old drugs, led to higher prices. It’s scrapped. So now what?